Amgen Q3 2026 Results: Net Income $3.86B, Up 20.1% YoY
Amgen reported total revenues of $10.37 billion for the third quarter of 2026, an 8% increase compared to the same period in 2025, driven primarily by product sales growth. Net income rose to $3.86 billion, or $7.08 per diluted share, benefiting from higher operating income and significant other income gains.
- Key figure
- Net income $3.86B · +20.1% YoY